CCL2 and peripheral arterial disease: CCL2 is likely to have considerable impact on PAD since the biological function of this chemokine is to induce monocyte migration and, as well, because the arteries with moderate atherosclerosis appear to accumulate CCL2 in response to a variety of pro-inflammatory stimuli [24,30,41,42,43,44].